The Swiss company, one of the world's biggest drugmakers, said the risk of Britain leaving the European Union, its biggest trading partner, without a deal had risen after Prime Minister Theresa May failed to get her deal through parliament last week. "Given the complex nature of the supply chain, government needs to implement a comprehensive continuity plan rapidly," Novartis said http://bit.ly/2RTMH8k in a statement. Novartis's fastest-growing medicine is Cosentyx, the blockbuster medicine for psoriasis and other auto-immune disorders including ankylosing spondylitis.
from Yahoo News - Latest News & Headlines https://yhoo.it/2SeuNwp
0 comments:
Post a Comment